Citron Research says Valeant Pharma (VRX) has better chance than HLF of 'going to $0'
Citron Research says Valeant Pharma (NYSE: VRX) has better chance than HLF of 'going to $0'. Citron said it will have more details on Monday. Calls company 'dirtier' than anyone has reported.
$VRX has a better chance of going to 0 than $HLF EVER will. Citron to update full story on Monday. Dirtier than anyone has reported!!
— Citron Research (@CitronResearch) October 30, 2015